CD14 and rheumatoid arthritis: In RA patients who were not treated with bDMARDs, the number of CD14-positive cells (×105) in the IFP was 1.64 (0.61–4.84); however, this number decreased to 0.42 (0.20–0.58) in the SC, with significance found (p = 0.00792).